nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—CYP1A2—Estropipate—osteoporosis	0.0595	0.0895	CbGbCtD
Propafenone—CYP2C9—Estropipate—osteoporosis	0.0536	0.0806	CbGbCtD
Propafenone—CYP2C8—Raloxifene—osteoporosis	0.0513	0.0771	CbGbCtD
Propafenone—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0495	0.0745	CbGbCtD
Propafenone—CYP2C8—Cholecalciferol—osteoporosis	0.0396	0.0595	CbGbCtD
Propafenone—ABCB1—Ethinyl Estradiol—osteoporosis	0.0335	0.0504	CbGbCtD
Propafenone—CYP2C8—Estradiol—osteoporosis	0.0319	0.048	CbGbCtD
Propafenone—CYP3A4—Estropipate—osteoporosis	0.0312	0.0469	CbGbCtD
Propafenone—CYP3A4—Calcitriol—osteoporosis	0.0312	0.0469	CbGbCtD
Propafenone—CYP1A2—Conjugated Estrogens—osteoporosis	0.0281	0.0423	CbGbCtD
Propafenone—CYP2C9—Cholecalciferol—osteoporosis	0.0276	0.0415	CbGbCtD
Propafenone—CYP2D6—Cholecalciferol—osteoporosis	0.0253	0.038	CbGbCtD
Propafenone—CYP3A4—Ergocalciferol—osteoporosis	0.0249	0.0375	CbGbCtD
Propafenone—CYP1A2—Estradiol—osteoporosis	0.0247	0.0371	CbGbCtD
Propafenone—ABCB1—Conjugated Estrogens—osteoporosis	0.0246	0.037	CbGbCtD
Propafenone—CYP2C9—Estradiol—osteoporosis	0.0223	0.0335	CbGbCtD
Propafenone—ABCB1—Estradiol—osteoporosis	0.0216	0.0325	CbGbCtD
Propafenone—CYP3A4—Raloxifene—osteoporosis	0.0208	0.0313	CbGbCtD
Propafenone—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0201	0.0302	CbGbCtD
Propafenone—CYP3A4—Cholecalciferol—osteoporosis	0.0161	0.0241	CbGbCtD
Propafenone—CYP3A4—Conjugated Estrogens—osteoporosis	0.0147	0.0222	CbGbCtD
Propafenone—CYP3A4—Estradiol—osteoporosis	0.0129	0.0195	CbGbCtD
Propafenone—Benazepril—MTHFR—osteoporosis	0.00116	0.363	CrCbGaD
Propafenone—Quinapril—ACE—osteoporosis	0.00108	0.34	CrCbGaD
Propafenone—Benazepril—ACE—osteoporosis	0.000942	0.296	CrCbGaD
Propafenone—Asthenia—Alendronate—osteoporosis	0.000177	0.000554	CcSEcCtD
Propafenone—Hypersensitivity—Ibandronate—osteoporosis	0.000177	0.000554	CcSEcCtD
Propafenone—Cough—Conjugated Estrogens—osteoporosis	0.000177	0.000554	CcSEcCtD
Propafenone—Dyspnoea—Risedronate—osteoporosis	0.000177	0.000553	CcSEcCtD
Propafenone—Hypotension—Pamidronate—osteoporosis	0.000176	0.000551	CcSEcCtD
Propafenone—Convulsion—Conjugated Estrogens—osteoporosis	0.000176	0.00055	CcSEcCtD
Propafenone—Dry mouth—Zoledronate—osteoporosis	0.000176	0.000549	CcSEcCtD
Propafenone—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000176	0.000549	CcSEcCtD
Propafenone—Fatigue—Ethinyl Estradiol—osteoporosis	0.000175	0.000548	CcSEcCtD
Propafenone—Pruritus—Alendronate—osteoporosis	0.000175	0.000547	CcSEcCtD
Propafenone—Dyspepsia—Risedronate—osteoporosis	0.000175	0.000546	CcSEcCtD
Propafenone—Eye disorder—Estradiol—osteoporosis	0.000174	0.000546	CcSEcCtD
Propafenone—Tinnitus—Estradiol—osteoporosis	0.000174	0.000545	CcSEcCtD
Propafenone—Constipation—Ethinyl Estradiol—osteoporosis	0.000174	0.000544	CcSEcCtD
Propafenone—Confusional state—Zoledronate—osteoporosis	0.000174	0.000543	CcSEcCtD
Propafenone—Hypersensitivity—Calcitriol—osteoporosis	0.000173	0.000543	CcSEcCtD
Propafenone—Flushing—Estradiol—osteoporosis	0.000173	0.000542	CcSEcCtD
Propafenone—Cardiac disorder—Estradiol—osteoporosis	0.000173	0.000542	CcSEcCtD
Propafenone—Chest pain—Conjugated Estrogens—osteoporosis	0.000173	0.000541	CcSEcCtD
Propafenone—Myalgia—Conjugated Estrogens—osteoporosis	0.000173	0.000541	CcSEcCtD
Propafenone—Asthenia—Ibandronate—osteoporosis	0.000173	0.00054	CcSEcCtD
Propafenone—Anxiety—Conjugated Estrogens—osteoporosis	0.000172	0.000539	CcSEcCtD
Propafenone—Nausea—Etidronic acid—osteoporosis	0.000172	0.000539	CcSEcCtD
Propafenone—Oedema—Zoledronate—osteoporosis	0.000172	0.000538	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000172	0.000537	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000172	0.000537	CcSEcCtD
Propafenone—Diarrhoea—Estropipate—osteoporosis	0.000172	0.000537	CcSEcCtD
Propafenone—Gastrointestinal disorder—Risedronate—osteoporosis	0.000171	0.000535	CcSEcCtD
Propafenone—Infection—Zoledronate—osteoporosis	0.000171	0.000535	CcSEcCtD
Propafenone—Fatigue—Risedronate—osteoporosis	0.000171	0.000535	CcSEcCtD
Propafenone—Insomnia—Pamidronate—osteoporosis	0.00017	0.000533	CcSEcCtD
Propafenone—Pruritus—Ibandronate—osteoporosis	0.00017	0.000532	CcSEcCtD
Propafenone—Pain—Risedronate—osteoporosis	0.00017	0.00053	CcSEcCtD
Propafenone—Constipation—Risedronate—osteoporosis	0.00017	0.00053	CcSEcCtD
Propafenone—Angiopathy—Estradiol—osteoporosis	0.000169	0.00053	CcSEcCtD
Propafenone—Shock—Zoledronate—osteoporosis	0.000169	0.00053	CcSEcCtD
Propafenone—Paraesthesia—Pamidronate—osteoporosis	0.000169	0.000529	CcSEcCtD
Propafenone—Diarrhoea—Alendronate—osteoporosis	0.000169	0.000529	CcSEcCtD
Propafenone—Asthenia—Calcitriol—osteoporosis	0.000169	0.000528	CcSEcCtD
Propafenone—Nervous system disorder—Zoledronate—osteoporosis	0.000169	0.000528	CcSEcCtD
Propafenone—Immune system disorder—Estradiol—osteoporosis	0.000169	0.000528	CcSEcCtD
Propafenone—Thrombocytopenia—Zoledronate—osteoporosis	0.000169	0.000527	CcSEcCtD
Propafenone—Mediastinal disorder—Estradiol—osteoporosis	0.000168	0.000526	CcSEcCtD
Propafenone—Dyspnoea—Pamidronate—osteoporosis	0.000168	0.000526	CcSEcCtD
Propafenone—Tachycardia—Zoledronate—osteoporosis	0.000168	0.000525	CcSEcCtD
Propafenone—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000168	0.000524	CcSEcCtD
Propafenone—Somnolence—Pamidronate—osteoporosis	0.000168	0.000524	CcSEcCtD
Propafenone—Skin disorder—Zoledronate—osteoporosis	0.000167	0.000523	CcSEcCtD
Propafenone—Pruritus—Calcitriol—osteoporosis	0.000167	0.000521	CcSEcCtD
Propafenone—Hyperhidrosis—Zoledronate—osteoporosis	0.000166	0.000521	CcSEcCtD
Propafenone—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000166	0.00052	CcSEcCtD
Propafenone—Diarrhoea—Raloxifene—osteoporosis	0.000166	0.00052	CcSEcCtD
Propafenone—Dyspepsia—Pamidronate—osteoporosis	0.000166	0.000519	CcSEcCtD
Propafenone—Dizziness—Estropipate—osteoporosis	0.000166	0.000519	CcSEcCtD
Propafenone—Oedema—Conjugated Estrogens—osteoporosis	0.000166	0.000518	CcSEcCtD
Propafenone—Alopecia—Estradiol—osteoporosis	0.000165	0.000516	CcSEcCtD
Propafenone—Infection—Conjugated Estrogens—osteoporosis	0.000165	0.000515	CcSEcCtD
Propafenone—Diarrhoea—Ibandronate—osteoporosis	0.000165	0.000515	CcSEcCtD
Propafenone—Anorexia—Zoledronate—osteoporosis	0.000164	0.000513	CcSEcCtD
Propafenone—Decreased appetite—Pamidronate—osteoporosis	0.000164	0.000512	CcSEcCtD
Propafenone—Mental disorder—Estradiol—osteoporosis	0.000164	0.000512	CcSEcCtD
Propafenone—Dizziness—Alendronate—osteoporosis	0.000163	0.000511	CcSEcCtD
Propafenone—Shock—Conjugated Estrogens—osteoporosis	0.000163	0.00051	CcSEcCtD
Propafenone—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000163	0.000509	CcSEcCtD
Propafenone—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000163	0.000508	CcSEcCtD
Propafenone—Erythema—Estradiol—osteoporosis	0.000163	0.000508	CcSEcCtD
Propafenone—Malnutrition—Estradiol—osteoporosis	0.000163	0.000508	CcSEcCtD
Propafenone—Fatigue—Pamidronate—osteoporosis	0.000162	0.000508	CcSEcCtD
Propafenone—Gastrointestinal pain—Risedronate—osteoporosis	0.000162	0.000507	CcSEcCtD
Propafenone—Tachycardia—Conjugated Estrogens—osteoporosis	0.000162	0.000506	CcSEcCtD
Propafenone—Urticaria—Ethinyl Estradiol—osteoporosis	0.000162	0.000505	CcSEcCtD
Propafenone—Pain—Pamidronate—osteoporosis	0.000161	0.000504	CcSEcCtD
Propafenone—Constipation—Pamidronate—osteoporosis	0.000161	0.000504	CcSEcCtD
Propafenone—Diarrhoea—Calcitriol—osteoporosis	0.000161	0.000504	CcSEcCtD
Propafenone—Skin disorder—Conjugated Estrogens—osteoporosis	0.000161	0.000504	CcSEcCtD
Propafenone—Hypotension—Zoledronate—osteoporosis	0.000161	0.000503	CcSEcCtD
Propafenone—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000161	0.000503	CcSEcCtD
Propafenone—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000161	0.000503	CcSEcCtD
Propafenone—Dizziness—Raloxifene—osteoporosis	0.000161	0.000503	CcSEcCtD
Propafenone—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00016	0.000501	CcSEcCtD
Propafenone—Flatulence—Estradiol—osteoporosis	0.00016	0.000501	CcSEcCtD
Propafenone—Tension—Estradiol—osteoporosis	0.00016	0.000499	CcSEcCtD
Propafenone—Vomiting—Estropipate—osteoporosis	0.000159	0.000499	CcSEcCtD
Propafenone—Dysgeusia—Estradiol—osteoporosis	0.000159	0.000498	CcSEcCtD
Propafenone—Dizziness—Ibandronate—osteoporosis	0.000159	0.000498	CcSEcCtD
Propafenone—Rash—Estropipate—osteoporosis	0.000158	0.000495	CcSEcCtD
Propafenone—Dermatitis—Estropipate—osteoporosis	0.000158	0.000494	CcSEcCtD
Propafenone—Anorexia—Conjugated Estrogens—osteoporosis	0.000158	0.000494	CcSEcCtD
Propafenone—Nervousness—Estradiol—osteoporosis	0.000158	0.000494	CcSEcCtD
Propafenone—Urticaria—Risedronate—osteoporosis	0.000157	0.000493	CcSEcCtD
Propafenone—Headache—Estropipate—osteoporosis	0.000157	0.000492	CcSEcCtD
Propafenone—Vomiting—Alendronate—osteoporosis	0.000157	0.000491	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000157	0.000491	CcSEcCtD
Propafenone—Body temperature increased—Risedronate—osteoporosis	0.000157	0.00049	CcSEcCtD
Propafenone—Abdominal pain—Risedronate—osteoporosis	0.000157	0.00049	CcSEcCtD
Propafenone—Muscle spasms—Estradiol—osteoporosis	0.000156	0.000489	CcSEcCtD
Propafenone—Rash—Alendronate—osteoporosis	0.000156	0.000487	CcSEcCtD
Propafenone—Insomnia—Zoledronate—osteoporosis	0.000156	0.000487	CcSEcCtD
Propafenone—Dermatitis—Alendronate—osteoporosis	0.000156	0.000487	CcSEcCtD
Propafenone—Feeling abnormal—Pamidronate—osteoporosis	0.000155	0.000486	CcSEcCtD
Propafenone—Hypotension—Conjugated Estrogens—osteoporosis	0.000155	0.000484	CcSEcCtD
Propafenone—Headache—Alendronate—osteoporosis	0.000155	0.000484	CcSEcCtD
Propafenone—Paraesthesia—Zoledronate—osteoporosis	0.000155	0.000483	CcSEcCtD
Propafenone—Vomiting—Raloxifene—osteoporosis	0.000154	0.000483	CcSEcCtD
Propafenone—Gastrointestinal pain—Pamidronate—osteoporosis	0.000154	0.000482	CcSEcCtD
Propafenone—Dyspnoea—Zoledronate—osteoporosis	0.000153	0.00048	CcSEcCtD
Propafenone—Rash—Raloxifene—osteoporosis	0.000153	0.000479	CcSEcCtD
Propafenone—Dermatitis—Raloxifene—osteoporosis	0.000153	0.000479	CcSEcCtD
Propafenone—Somnolence—Zoledronate—osteoporosis	0.000153	0.000479	CcSEcCtD
Propafenone—Vomiting—Ibandronate—osteoporosis	0.000153	0.000478	CcSEcCtD
Propafenone—Tremor—Estradiol—osteoporosis	0.000152	0.000476	CcSEcCtD
Propafenone—Headache—Raloxifene—osteoporosis	0.000152	0.000476	CcSEcCtD
Propafenone—Rash—Ibandronate—osteoporosis	0.000152	0.000474	CcSEcCtD
Propafenone—Dermatitis—Ibandronate—osteoporosis	0.000152	0.000474	CcSEcCtD
Propafenone—Dyspepsia—Zoledronate—osteoporosis	0.000152	0.000474	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000151	0.000472	CcSEcCtD
Propafenone—Ill-defined disorder—Estradiol—osteoporosis	0.000151	0.000472	CcSEcCtD
Propafenone—Headache—Ibandronate—osteoporosis	0.000151	0.000471	CcSEcCtD
Propafenone—Insomnia—Conjugated Estrogens—osteoporosis	0.00015	0.000469	CcSEcCtD
Propafenone—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00015	0.000469	CcSEcCtD
Propafenone—Vomiting—Calcitriol—osteoporosis	0.00015	0.000468	CcSEcCtD
Propafenone—Decreased appetite—Zoledronate—osteoporosis	0.00015	0.000468	CcSEcCtD
Propafenone—Nausea—Estropipate—osteoporosis	0.000149	0.000466	CcSEcCtD
Propafenone—Body temperature increased—Pamidronate—osteoporosis	0.000149	0.000466	CcSEcCtD
Propafenone—Abdominal pain—Pamidronate—osteoporosis	0.000149	0.000466	CcSEcCtD
Propafenone—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000149	0.000466	CcSEcCtD
Propafenone—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000149	0.000465	CcSEcCtD
Propafenone—Rash—Calcitriol—osteoporosis	0.000148	0.000464	CcSEcCtD
Propafenone—Fatigue—Zoledronate—osteoporosis	0.000148	0.000464	CcSEcCtD
Propafenone—Dermatitis—Calcitriol—osteoporosis	0.000148	0.000464	CcSEcCtD
Propafenone—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000148	0.000462	CcSEcCtD
Propafenone—Headache—Calcitriol—osteoporosis	0.000148	0.000461	CcSEcCtD
Propafenone—Somnolence—Conjugated Estrogens—osteoporosis	0.000147	0.000461	CcSEcCtD
Propafenone—Constipation—Zoledronate—osteoporosis	0.000147	0.00046	CcSEcCtD
Propafenone—Pain—Zoledronate—osteoporosis	0.000147	0.00046	CcSEcCtD
Propafenone—Nausea—Alendronate—osteoporosis	0.000147	0.000459	CcSEcCtD
Propafenone—Malaise—Estradiol—osteoporosis	0.000147	0.000458	CcSEcCtD
Propafenone—Hypersensitivity—Risedronate—osteoporosis	0.000146	0.000457	CcSEcCtD
Propafenone—Vertigo—Estradiol—osteoporosis	0.000146	0.000457	CcSEcCtD
Propafenone—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000146	0.000456	CcSEcCtD
Propafenone—Asthenia—Ethinyl Estradiol—osteoporosis	0.000146	0.000456	CcSEcCtD
Propafenone—Syncope—Estradiol—osteoporosis	0.000146	0.000456	CcSEcCtD
Propafenone—Nausea—Raloxifene—osteoporosis	0.000144	0.000451	CcSEcCtD
Propafenone—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000144	0.000451	CcSEcCtD
Propafenone—Pruritus—Ethinyl Estradiol—osteoporosis	0.000144	0.00045	CcSEcCtD
Propafenone—Palpitations—Estradiol—osteoporosis	0.000144	0.000449	CcSEcCtD
Propafenone—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000143	0.000448	CcSEcCtD
Propafenone—Fatigue—Conjugated Estrogens—osteoporosis	0.000143	0.000447	CcSEcCtD
Propafenone—Nausea—Ibandronate—osteoporosis	0.000143	0.000447	CcSEcCtD
Propafenone—Loss of consciousness—Estradiol—osteoporosis	0.000143	0.000447	CcSEcCtD
Propafenone—Asthenia—Risedronate—osteoporosis	0.000142	0.000445	CcSEcCtD
Propafenone—Feeling abnormal—Zoledronate—osteoporosis	0.000142	0.000444	CcSEcCtD
Propafenone—Cough—Estradiol—osteoporosis	0.000142	0.000444	CcSEcCtD
Propafenone—Constipation—Conjugated Estrogens—osteoporosis	0.000142	0.000443	CcSEcCtD
Propafenone—Pain—Conjugated Estrogens—osteoporosis	0.000142	0.000443	CcSEcCtD
Propafenone—Gastrointestinal pain—Zoledronate—osteoporosis	0.000141	0.00044	CcSEcCtD
Propafenone—Hypertension—Estradiol—osteoporosis	0.00014	0.000439	CcSEcCtD
Propafenone—Pruritus—Risedronate—osteoporosis	0.00014	0.000439	CcSEcCtD
Propafenone—Nausea—Calcitriol—osteoporosis	0.00014	0.000437	CcSEcCtD
Propafenone—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000139	0.000435	CcSEcCtD
Propafenone—Hypersensitivity—Pamidronate—osteoporosis	0.000139	0.000434	CcSEcCtD
Propafenone—Chest pain—Estradiol—osteoporosis	0.000138	0.000433	CcSEcCtD
Propafenone—Myalgia—Estradiol—osteoporosis	0.000138	0.000433	CcSEcCtD
Propafenone—Anxiety—Estradiol—osteoporosis	0.000138	0.000431	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000137	0.00043	CcSEcCtD
Propafenone—Urticaria—Zoledronate—osteoporosis	0.000137	0.000428	CcSEcCtD
Propafenone—Discomfort—Estradiol—osteoporosis	0.000137	0.000428	CcSEcCtD
Propafenone—Abdominal pain—Zoledronate—osteoporosis	0.000136	0.000426	CcSEcCtD
Propafenone—Body temperature increased—Zoledronate—osteoporosis	0.000136	0.000426	CcSEcCtD
Propafenone—Diarrhoea—Risedronate—osteoporosis	0.000136	0.000424	CcSEcCtD
Propafenone—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000136	0.000424	CcSEcCtD
Propafenone—Dry mouth—Estradiol—osteoporosis	0.000135	0.000423	CcSEcCtD
Propafenone—Asthenia—Pamidronate—osteoporosis	0.000135	0.000423	CcSEcCtD
Propafenone—Dizziness—Ethinyl Estradiol—osteoporosis	0.000134	0.000421	CcSEcCtD
Propafenone—Confusional state—Estradiol—osteoporosis	0.000134	0.000418	CcSEcCtD
Propafenone—Pruritus—Pamidronate—osteoporosis	0.000133	0.000417	CcSEcCtD
Propafenone—Oedema—Estradiol—osteoporosis	0.000133	0.000415	CcSEcCtD
Propafenone—Infection—Estradiol—osteoporosis	0.000132	0.000412	CcSEcCtD
Propafenone—Urticaria—Conjugated Estrogens—osteoporosis	0.000132	0.000412	CcSEcCtD
Propafenone—Dizziness—Risedronate—osteoporosis	0.000131	0.00041	CcSEcCtD
Propafenone—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000131	0.00041	CcSEcCtD
Propafenone—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000131	0.00041	CcSEcCtD
Propafenone—Shock—Estradiol—osteoporosis	0.000131	0.000408	CcSEcCtD
Propafenone—Nervous system disorder—Estradiol—osteoporosis	0.00013	0.000407	CcSEcCtD
Propafenone—Tachycardia—Estradiol—osteoporosis	0.000129	0.000405	CcSEcCtD
Propafenone—Vomiting—Ethinyl Estradiol—osteoporosis	0.000129	0.000404	CcSEcCtD
Propafenone—Diarrhoea—Pamidronate—osteoporosis	0.000129	0.000403	CcSEcCtD
Propafenone—Skin disorder—Estradiol—osteoporosis	0.000129	0.000403	CcSEcCtD
Propafenone—Hyperhidrosis—Estradiol—osteoporosis	0.000128	0.000401	CcSEcCtD
Propafenone—Rash—Ethinyl Estradiol—osteoporosis	0.000128	0.000401	CcSEcCtD
Propafenone—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000128	0.000401	CcSEcCtD
Propafenone—Headache—Ethinyl Estradiol—osteoporosis	0.000127	0.000398	CcSEcCtD
Propafenone—Hypersensitivity—Zoledronate—osteoporosis	0.000127	0.000397	CcSEcCtD
Propafenone—Vomiting—Risedronate—osteoporosis	0.000126	0.000394	CcSEcCtD
Propafenone—Rash—Risedronate—osteoporosis	0.000125	0.000391	CcSEcCtD
Propafenone—Dermatitis—Risedronate—osteoporosis	0.000125	0.000391	CcSEcCtD
Propafenone—Dizziness—Pamidronate—osteoporosis	0.000125	0.00039	CcSEcCtD
Propafenone—Headache—Risedronate—osteoporosis	0.000124	0.000388	CcSEcCtD
Propafenone—Asthenia—Zoledronate—osteoporosis	0.000124	0.000386	CcSEcCtD
Propafenone—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000122	0.000382	CcSEcCtD
Propafenone—Pruritus—Zoledronate—osteoporosis	0.000122	0.000381	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000121	0.000378	CcSEcCtD
Propafenone—Nausea—Ethinyl Estradiol—osteoporosis	0.000121	0.000378	CcSEcCtD
Propafenone—Insomnia—Estradiol—osteoporosis	0.00012	0.000375	CcSEcCtD
Propafenone—Vomiting—Pamidronate—osteoporosis	0.00012	0.000375	CcSEcCtD
Propafenone—Paraesthesia—Estradiol—osteoporosis	0.000119	0.000373	CcSEcCtD
Propafenone—Asthenia—Conjugated Estrogens—osteoporosis	0.000119	0.000372	CcSEcCtD
Propafenone—Rash—Pamidronate—osteoporosis	0.000119	0.000372	CcSEcCtD
Propafenone—Dermatitis—Pamidronate—osteoporosis	0.000119	0.000371	CcSEcCtD
Propafenone—Dyspnoea—Estradiol—osteoporosis	0.000118	0.00037	CcSEcCtD
Propafenone—Headache—Pamidronate—osteoporosis	0.000118	0.000369	CcSEcCtD
Propafenone—Somnolence—Estradiol—osteoporosis	0.000118	0.000369	CcSEcCtD
Propafenone—Diarrhoea—Zoledronate—osteoporosis	0.000118	0.000368	CcSEcCtD
Propafenone—Nausea—Risedronate—osteoporosis	0.000118	0.000368	CcSEcCtD
Propafenone—Pruritus—Conjugated Estrogens—osteoporosis	0.000117	0.000367	CcSEcCtD
Propafenone—Dyspepsia—Estradiol—osteoporosis	0.000117	0.000365	CcSEcCtD
Propafenone—Decreased appetite—Estradiol—osteoporosis	0.000115	0.000361	CcSEcCtD
Propafenone—Gastrointestinal disorder—Estradiol—osteoporosis	0.000115	0.000358	CcSEcCtD
Propafenone—Fatigue—Estradiol—osteoporosis	0.000114	0.000358	CcSEcCtD
Propafenone—Dizziness—Zoledronate—osteoporosis	0.000114	0.000356	CcSEcCtD
Propafenone—Pain—Estradiol—osteoporosis	0.000113	0.000355	CcSEcCtD
Propafenone—Constipation—Estradiol—osteoporosis	0.000113	0.000355	CcSEcCtD
Propafenone—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000113	0.000355	CcSEcCtD
Propafenone—Nausea—Pamidronate—osteoporosis	0.000112	0.00035	CcSEcCtD
Propafenone—Dizziness—Conjugated Estrogens—osteoporosis	0.00011	0.000343	CcSEcCtD
Propafenone—Vomiting—Zoledronate—osteoporosis	0.000109	0.000342	CcSEcCtD
Propafenone—Feeling abnormal—Estradiol—osteoporosis	0.000109	0.000342	CcSEcCtD
Propafenone—Rash—Zoledronate—osteoporosis	0.000109	0.000339	CcSEcCtD
Propafenone—Gastrointestinal pain—Estradiol—osteoporosis	0.000108	0.000339	CcSEcCtD
Propafenone—Dermatitis—Zoledronate—osteoporosis	0.000108	0.000339	CcSEcCtD
Propafenone—Headache—Zoledronate—osteoporosis	0.000108	0.000337	CcSEcCtD
Propafenone—Vomiting—Conjugated Estrogens—osteoporosis	0.000105	0.00033	CcSEcCtD
Propafenone—Urticaria—Estradiol—osteoporosis	0.000105	0.00033	CcSEcCtD
Propafenone—Body temperature increased—Estradiol—osteoporosis	0.000105	0.000328	CcSEcCtD
Propafenone—Abdominal pain—Estradiol—osteoporosis	0.000105	0.000328	CcSEcCtD
Propafenone—Rash—Conjugated Estrogens—osteoporosis	0.000105	0.000327	CcSEcCtD
Propafenone—Dermatitis—Conjugated Estrogens—osteoporosis	0.000104	0.000327	CcSEcCtD
Propafenone—Headache—Conjugated Estrogens—osteoporosis	0.000104	0.000325	CcSEcCtD
Propafenone—Nausea—Zoledronate—osteoporosis	0.000102	0.00032	CcSEcCtD
Propafenone—Nausea—Conjugated Estrogens—osteoporosis	9.85e-05	0.000308	CcSEcCtD
Propafenone—Hypersensitivity—Estradiol—osteoporosis	9.77e-05	0.000306	CcSEcCtD
Propafenone—Asthenia—Estradiol—osteoporosis	9.52e-05	0.000298	CcSEcCtD
Propafenone—Pruritus—Estradiol—osteoporosis	9.39e-05	0.000294	CcSEcCtD
Propafenone—Diarrhoea—Estradiol—osteoporosis	9.08e-05	0.000284	CcSEcCtD
Propafenone—Dizziness—Estradiol—osteoporosis	8.77e-05	0.000274	CcSEcCtD
Propafenone—Vomiting—Estradiol—osteoporosis	8.43e-05	0.000264	CcSEcCtD
Propafenone—Rash—Estradiol—osteoporosis	8.36e-05	0.000262	CcSEcCtD
Propafenone—Dermatitis—Estradiol—osteoporosis	8.36e-05	0.000261	CcSEcCtD
Propafenone—Headache—Estradiol—osteoporosis	8.31e-05	0.00026	CcSEcCtD
Propafenone—Nausea—Estradiol—osteoporosis	7.88e-05	0.000246	CcSEcCtD
Propafenone—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	2.32e-05	0.00196	CbGpPWpGaD
Propafenone—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	2.3e-05	0.00194	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SOST—osteoporosis	2.27e-05	0.00192	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—LEP—osteoporosis	2.27e-05	0.00192	CbGpPWpGaD
Propafenone—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.25e-05	0.0019	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.19e-05	0.00184	CbGpPWpGaD
Propafenone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	2.14e-05	0.00181	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—IL6—osteoporosis	2.13e-05	0.0018	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.13e-05	0.0018	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.09e-05	0.00177	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—IL1B—osteoporosis	2.07e-05	0.00175	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—IL6—osteoporosis	2.07e-05	0.00174	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CALCR—osteoporosis	2.06e-05	0.00174	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PTH1R—osteoporosis	2.06e-05	0.00174	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—PTH—osteoporosis	2.01e-05	0.0017	CbGpPWpGaD
Propafenone—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	1.99e-05	0.00168	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	1.99e-05	0.00168	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.98e-05	0.00167	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	1.98e-05	0.00167	CbGpPWpGaD
Propafenone—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	1.96e-05	0.00166	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—CNR2—osteoporosis	1.96e-05	0.00166	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—IL6R—osteoporosis	1.9e-05	0.00161	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.87e-05	0.00158	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	1.85e-05	0.00156	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	1.85e-05	0.00156	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—PTH—osteoporosis	1.83e-05	0.00154	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.82e-05	0.00154	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	1.79e-05	0.00151	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—CNR2—osteoporosis	1.78e-05	0.0015	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.78e-05	0.0015	CbGpPWpGaD
Propafenone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.74e-05	0.00147	CbGpPWpGaD
Propafenone—CYP2C8—Biological oxidations—POMC—osteoporosis	1.72e-05	0.00145	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.7e-05	0.00144	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—WNT1—osteoporosis	1.68e-05	0.00141	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—PTHLH—osteoporosis	1.67e-05	0.00141	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MGLL—osteoporosis	1.63e-05	0.00138	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—FDPS—osteoporosis	1.62e-05	0.00137	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PKM—osteoporosis	1.62e-05	0.00137	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—TGFB1—osteoporosis	1.61e-05	0.00136	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—LRP5—osteoporosis	1.59e-05	0.00135	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PGLS—osteoporosis	1.54e-05	0.0013	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GPD2—osteoporosis	1.54e-05	0.0013	CbGpPWpGaD
Propafenone—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.54e-05	0.0013	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	1.53e-05	0.00129	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—LRP6—osteoporosis	1.53e-05	0.00129	CbGpPWpGaD
Propafenone—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.52e-05	0.00128	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—PTHLH—osteoporosis	1.52e-05	0.00128	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—TNF—osteoporosis	1.5e-05	0.00127	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—CALCA—osteoporosis	1.47e-05	0.00124	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.46e-05	0.00123	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.45e-05	0.00122	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PKM—osteoporosis	1.41e-05	0.00119	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—FDPS—osteoporosis	1.41e-05	0.00119	CbGpPWpGaD
Propafenone—CYP2D6—Biological oxidations—POMC—osteoporosis	1.41e-05	0.00119	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PNP—osteoporosis	1.41e-05	0.00119	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ATIC—osteoporosis	1.41e-05	0.00119	CbGpPWpGaD
Propafenone—CYP2C9—Biological oxidations—POMC—osteoporosis	1.4e-05	0.00118	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—POMC—osteoporosis	1.36e-05	0.00115	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PGLS—osteoporosis	1.34e-05	0.00113	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GPD2—osteoporosis	1.34e-05	0.00113	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—CALCA—osteoporosis	1.33e-05	0.00113	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PKM—osteoporosis	1.33e-05	0.00112	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—FDPS—osteoporosis	1.33e-05	0.00112	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.33e-05	0.00112	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PKM—osteoporosis	1.32e-05	0.00111	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—FDPS—osteoporosis	1.32e-05	0.00111	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TLN1—osteoporosis	1.29e-05	0.00109	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GPD2—osteoporosis	1.26e-05	0.00107	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PGLS—osteoporosis	1.26e-05	0.00107	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PGLS—osteoporosis	1.25e-05	0.00106	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GPD2—osteoporosis	1.25e-05	0.00106	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.24e-05	0.00104	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ATIC—osteoporosis	1.23e-05	0.00103	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PNP—osteoporosis	1.23e-05	0.00103	CbGpPWpGaD
Propafenone—CYP1A2—Biological oxidations—POMC—osteoporosis	1.2e-05	0.00101	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—OXCT1—osteoporosis	1.2e-05	0.00101	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CA2—osteoporosis	1.2e-05	0.00101	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—IL6—osteoporosis	1.19e-05	0.001	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—MGLL—osteoporosis	1.17e-05	0.000984	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ATIC—osteoporosis	1.16e-05	0.000975	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PNP—osteoporosis	1.16e-05	0.000975	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PNP—osteoporosis	1.15e-05	0.000966	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ATIC—osteoporosis	1.15e-05	0.000966	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PKM—osteoporosis	1.13e-05	0.000952	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—FDPS—osteoporosis	1.13e-05	0.000952	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—TGFB1—osteoporosis	1.12e-05	0.000949	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—P4HB—osteoporosis	1.11e-05	0.000937	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.1e-05	0.000928	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PTH—osteoporosis	1.08e-05	0.000912	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GPD2—osteoporosis	1.07e-05	0.000903	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PGLS—osteoporosis	1.07e-05	0.000903	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—RAP1A—osteoporosis	1.06e-05	0.000896	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CNR2—osteoporosis	1.05e-05	0.000888	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—TNF—osteoporosis	1.05e-05	0.000886	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—ADCY5—osteoporosis	1.05e-05	0.000882	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CA2—osteoporosis	1.04e-05	0.00088	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—OXCT1—osteoporosis	1.04e-05	0.00088	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NFATC1—osteoporosis	1.04e-05	0.000874	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—DKK1—osteoporosis	1.03e-05	0.000867	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—MGLL—osteoporosis	1.02e-05	0.000857	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—IDH2—osteoporosis	9.91e-06	0.000837	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—WNT1—osteoporosis	9.9e-06	0.000835	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CA2—osteoporosis	9.82e-06	0.000829	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—OXCT1—osteoporosis	9.82e-06	0.000829	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PNP—osteoporosis	9.79e-06	0.000826	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ATIC—osteoporosis	9.79e-06	0.000826	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CA2—osteoporosis	9.74e-06	0.000822	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—OXCT1—osteoporosis	9.74e-06	0.000822	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—FGA—osteoporosis	9.63e-06	0.000813	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—MGLL—osteoporosis	9.57e-06	0.000808	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—ADCY5—osteoporosis	9.49e-06	0.000801	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—MGLL—osteoporosis	9.49e-06	0.000801	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP27A1—osteoporosis	9.32e-06	0.000787	CbGpPWpGaD
Propafenone—CYP3A4—Biological oxidations—POMC—osteoporosis	9.24e-06	0.000779	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ACP5—osteoporosis	9.07e-06	0.000765	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	8.95e-06	0.000755	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PTHLH—osteoporosis	8.95e-06	0.000755	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—BMP2—osteoporosis	8.95e-06	0.000755	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	8.95e-06	0.000755	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—FGB—osteoporosis	8.76e-06	0.000739	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—FDPS—osteoporosis	8.71e-06	0.000735	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PKM—osteoporosis	8.71e-06	0.000735	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—IDH2—osteoporosis	8.64e-06	0.000729	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—IL6—osteoporosis	8.48e-06	0.000715	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PSMA2—osteoporosis	8.46e-06	0.000714	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PSMA5—osteoporosis	8.46e-06	0.000714	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—TPI1—osteoporosis	8.43e-06	0.000711	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—OXCT1—osteoporosis	8.32e-06	0.000702	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CA2—osteoporosis	8.32e-06	0.000702	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GPD2—osteoporosis	8.26e-06	0.000697	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PGLS—osteoporosis	8.26e-06	0.000697	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—IDH2—osteoporosis	8.14e-06	0.000687	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP27A1—osteoporosis	8.12e-06	0.000685	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—MGLL—osteoporosis	8.11e-06	0.000684	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—IDH2—osteoporosis	8.07e-06	0.000681	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	7.97e-06	0.000672	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	7.95e-06	0.000671	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—P4HB—osteoporosis	7.93e-06	0.000669	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ACP5—osteoporosis	7.9e-06	0.000667	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CALCA—osteoporosis	7.88e-06	0.000665	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GAPDH—osteoporosis	7.78e-06	0.000656	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—POMC—osteoporosis	7.69e-06	0.000649	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP27A1—osteoporosis	7.65e-06	0.000646	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	7.65e-06	0.000645	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP27A1—osteoporosis	7.59e-06	0.00064	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—RAP1A—osteoporosis	7.58e-06	0.000639	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ATIC—osteoporosis	7.55e-06	0.000637	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PNP—osteoporosis	7.55e-06	0.000637	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ACP5—osteoporosis	7.44e-06	0.000628	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	7.44e-06	0.000628	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	7.42e-06	0.000626	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ACP5—osteoporosis	7.38e-06	0.000623	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—TPI1—osteoporosis	7.34e-06	0.00062	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	7.29e-06	0.000615	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—KL—osteoporosis	7.16e-06	0.000604	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—POMC—osteoporosis	6.98e-06	0.000589	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—TPI1—osteoporosis	6.92e-06	0.000584	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—P4HB—osteoporosis	6.91e-06	0.000583	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—IDH2—osteoporosis	6.9e-06	0.000582	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—TPI1—osteoporosis	6.86e-06	0.000579	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—IL6R—osteoporosis	6.81e-06	0.000575	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GAPDH—osteoporosis	6.78e-06	0.000572	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.61e-06	0.000558	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—RAP1A—osteoporosis	6.6e-06	0.000557	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—P4HB—osteoporosis	6.51e-06	0.000549	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP27A1—osteoporosis	6.48e-06	0.000547	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—P4HB—osteoporosis	6.45e-06	0.000544	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CA2—osteoporosis	6.42e-06	0.000542	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—OXCT1—osteoporosis	6.42e-06	0.000542	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GAPDH—osteoporosis	6.39e-06	0.000539	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GAPDH—osteoporosis	6.33e-06	0.000534	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ACP5—osteoporosis	6.31e-06	0.000532	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—MGLL—osteoporosis	6.26e-06	0.000528	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.23e-06	0.000525	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—RAP1A—osteoporosis	6.22e-06	0.000525	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—RAP1A—osteoporosis	6.17e-06	0.00052	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ENO1—osteoporosis	6.13e-06	0.000517	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PSMA2—osteoporosis	6.04e-06	0.000509	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PSMA5—osteoporosis	6.04e-06	0.000509	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—TPI1—osteoporosis	5.86e-06	0.000495	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ADCY5—osteoporosis	5.61e-06	0.000473	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—P4HB—osteoporosis	5.51e-06	0.000465	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SPP1—osteoporosis	5.42e-06	0.000458	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GAPDH—osteoporosis	5.41e-06	0.000457	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.38e-06	0.000454	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ENO1—osteoporosis	5.34e-06	0.00045	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—IDH2—osteoporosis	5.32e-06	0.000449	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—RAP1A—osteoporosis	5.27e-06	0.000445	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PSMA2—osteoporosis	5.26e-06	0.000444	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PSMA5—osteoporosis	5.26e-06	0.000444	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ENO1—osteoporosis	5.03e-06	0.000424	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP27A1—osteoporosis	5e-06	0.000422	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ENO1—osteoporosis	4.99e-06	0.000421	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PSMA5—osteoporosis	4.96e-06	0.000418	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PSMA2—osteoporosis	4.96e-06	0.000418	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PSMA2—osteoporosis	4.91e-06	0.000414	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PSMA5—osteoporosis	4.91e-06	0.000414	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IRS2—osteoporosis	4.91e-06	0.000414	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP19A1—osteoporosis	4.9e-06	0.000413	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ACP5—osteoporosis	4.87e-06	0.000411	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—LEP—osteoporosis	4.8e-06	0.000405	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.6e-06	0.000388	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ESR1—osteoporosis	4.58e-06	0.000387	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—TPI1—osteoporosis	4.53e-06	0.000382	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IRS1—osteoporosis	4.28e-06	0.000361	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP19A1—osteoporosis	4.27e-06	0.00036	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ENO1—osteoporosis	4.26e-06	0.000359	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—P4HB—osteoporosis	4.25e-06	0.000359	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PSMA2—osteoporosis	4.2e-06	0.000354	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PSMA5—osteoporosis	4.2e-06	0.000354	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GAPDH—osteoporosis	4.18e-06	0.000352	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—POMC—osteoporosis	4.12e-06	0.000348	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—RAP1A—osteoporosis	4.07e-06	0.000343	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL6R—osteoporosis	4.02e-06	0.000339	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP19A1—osteoporosis	4.02e-06	0.000339	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ADCY5—osteoporosis	4e-06	0.000338	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GPX1—osteoporosis	3.99e-06	0.000336	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP19A1—osteoporosis	3.99e-06	0.000336	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IGF1—osteoporosis	3.97e-06	0.000335	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—MTHFR—osteoporosis	3.68e-06	0.00031	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ADCY5—osteoporosis	3.49e-06	0.000294	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GPX1—osteoporosis	3.47e-06	0.000293	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP19A1—osteoporosis	3.41e-06	0.000287	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ENO1—osteoporosis	3.29e-06	0.000277	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ADCY5—osteoporosis	3.28e-06	0.000277	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GPX1—osteoporosis	3.27e-06	0.000276	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ADCY5—osteoporosis	3.26e-06	0.000275	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GPX1—osteoporosis	3.25e-06	0.000274	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PSMA5—osteoporosis	3.24e-06	0.000273	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PSMA2—osteoporosis	3.24e-06	0.000273	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—MTHFR—osteoporosis	3.21e-06	0.00027	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—IL6—osteoporosis	3.03e-06	0.000256	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—MTHFR—osteoporosis	3.02e-06	0.000255	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—MTHFR—osteoporosis	2.99e-06	0.000253	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—POMC—osteoporosis	2.94e-06	0.000248	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ADCY5—osteoporosis	2.78e-06	0.000235	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GPX1—osteoporosis	2.77e-06	0.000234	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP19A1—osteoporosis	2.63e-06	0.000222	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—POMC—osteoporosis	2.56e-06	0.000216	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—MTHFR—osteoporosis	2.56e-06	0.000216	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—POMC—osteoporosis	2.42e-06	0.000204	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—POMC—osteoporosis	2.4e-06	0.000202	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MYC—osteoporosis	2.38e-06	0.000201	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TGFB1—osteoporosis	2.38e-06	0.000201	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ADCY5—osteoporosis	2.15e-06	0.000181	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GPX1—osteoporosis	2.14e-06	0.000181	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—POMC—osteoporosis	2.05e-06	0.000173	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—MTHFR—osteoporosis	1.98e-06	0.000167	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL6—osteoporosis	1.79e-06	0.000151	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—POMC—osteoporosis	1.58e-06	0.000133	CbGpPWpGaD
